Literature DB >> 1426169

Cholesterol and other cardiovascular risk factors in a working population in Ile-de-France (France): first results of the PCV-METRA study.

D Laurier1, N P Chau, P Segond.   

Abstract

In 1989, the French PCV-METRA Group (PCV-METRA = Prevention Cardio-Vasculaire en Médecine du Travail) started a large prospective survey of cardiovascular (CDV) morbidity and mortality and of CVD risk factors, especially cholesterol, in a working population in Ile-de-France, a region including Paris. This report presents the first results of this study, based on a sample of 5758 men and 2603 women, aged 18-65 years. The variables examined included the levels of total cholesterol 1/2 (TC), High-density-lipoprotein cholesterol (HDL-C), low-density-lipoprotein cholesterol (LDL-C), and the other major CVD risk factors (smoking, sedentary way of life, hypertension, hypercholesterolemia, use of oral contraceptives and familial history of CVD risks). TC and LDL-C significantly increased with age. The changes with age were significantly different in men and women. The levels were similar in both sexes at less than 30 yrs, increased sharply for men after age 30 and were significantly higher in men than in women from 30 to 55 yrs. Beyond 55 yrs, no difference was observed between the two sexes. In contrast, HDL-C was higher in women at all age ranges. In the total sample, 35% of men and 21% of women were hypercholesterolemic (TC > or = 2.4 g/L). Our observations fully confirm and refine previous findings in the US and in other European countries. In addition, a substantial set of data on CVD risk factors for the working population in France, especially for female subjects for whom data are scanty, is now available.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426169     DOI: 10.1007/bf00145386

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  21 in total

1.  [The MONICA project. A WHO research project in cardiovascular diseases].

Authors:  J L Richard
Journal:  Rev Epidemiol Sante Publique       Date:  1988       Impact factor: 1.019

2.  Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; W P Castelli; T Gordon; P M McNamara
Journal:  Ann Intern Med       Date:  1971-01       Impact factor: 25.391

3.  Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group.

Authors: 
Journal:  J Chronic Dis       Date:  1978-04

Review 4.  The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association.

Authors:  J C LaRosa; D Hunninghake; D Bush; M H Criqui; G S Getz; A M Gotto; S M Grundy; L Rakita; R M Robertson; M L Weisfeldt
Journal:  Circulation       Date:  1990-05       Impact factor: 29.690

Review 5.  [Risk factors for atherosclerotic diseases in the Prospective Parisian Study I. Comparison with foreign studies].

Authors:  C Bloch; J L Richard
Journal:  Rev Epidemiol Sante Publique       Date:  1985       Impact factor: 1.019

6.  Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men.

Authors:  I Hjermann; K Velve Byre; I Holme; P Leren
Journal:  Lancet       Date:  1981-12-12       Impact factor: 79.321

7.  Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population.

Authors:  D J Lerner; W B Kannel
Journal:  Am Heart J       Date:  1986-02       Impact factor: 4.749

8.  Is the relationship between blood pressure and cardiovascular risk dependent on body mass index?

Authors:  F Cambien; J M Chretien; P Ducimetiere; L Guize; J L Richard
Journal:  Am J Epidemiol       Date:  1985-09       Impact factor: 4.897

9.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Authors:  D J Gordon; J L Probstfield; R J Garrison; J D Neaton; W P Castelli; J D Knoke; D R Jacobs; S Bangdiwala; H A Tyroler
Journal:  Circulation       Date:  1989-01       Impact factor: 29.690

10.  Coronary heart disease in middle-aged Frenchmen. Comparisons between Paris Prospective Study, Seven Countries Study, and Pooling Project.

Authors:  P Ducimetiere; J L Richard; F Cambien; R Rakotovao; J R Claude
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321

View more
  2 in total

1.  Why heart disease mortality is low in France: the time lag explanation.

Authors:  M Law; N Wald
Journal:  BMJ       Date:  1999-05-29

2.  Relevance of cholesterol screening in the United Arab Emirates. A preliminary study.

Authors:  M M Agarwal; P F Hughes; A A Haliga; P Newman; M M Sheekh-Hussen; A G Shalabi
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.